Skip to main content

Find Clinical Trials

Home
Conditions
Lung Neoplasms

Clinical trial condition

Lung Neoplasms

Explore clinical trials studying Lung Neoplasms. Study availability and eligibility vary by location and protocol.

4,207 public trials 1,003 recruiting studies

Refine in advanced search Browse all conditions

Lung Neoplasms trial results

Recruiting

A Study of Vebreltinib and Platinum-Containing Double Agents in Subjects With MET-Positive

NCT06930794

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: Cancer Hospital Chinese Academy of Medical Sciences Beijing, Beijing Municipality, China

Guangdong Provincial People's Hospital Guangzhou, Guangdong, China

View Trial Details

Recruiting

Feasibility and Effectiveness of Respiratory Movement Management in Lung Cancer Receiving Stereotactic Radiotherapy Using a Novel Positional Fixation Device

NCT07561567

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: Tianjin Medical University Cancer Institute and Hospital Tianjin, China

View Trial Details

Recruiting

This Study is an Open-lable, Early Study to Evaluate the Safety, Feasibility, Cytokinetics, and Preliminary Efficacy of GC511B in DLL3+ Relapsed/Refractory Small Cell Lung Cancer.

NCT07249879

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Lung Diseases, +8 more
Locations: Cancer Hospital, Chinese Academy of Medical Sciences Beijing, Beijing Municipality, China

Beijing Gobroad Hospital Beijing, Beijing Municipality, China

View Trial Details

Recruiting

Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients

NCT05899608

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: Banner University Medical Center Phoenix, Arizona, United States

TMC Healthcare Tucson, Arizona, United States

Genesis Cancer and Blood Institute Hot Springs, Arkansas, United States

University of Arkansas Little Rock, Arkansas, United States

View all 253 locations

View Trial Details

Recruiting

Shared Decision Making in Patients With Lung Cancer

NCT05191485

Conditions: Adenocarcinoma, Adenocarcinoma of Lung, Carcinoma, +9 more
Locations: Sichuan Cancer Hospital & Institute Chengdu, Sichuan, China

View Trial Details

Recruiting

Neoadjuvant SBRT Followed by Sintilimab Plus Chemotherapy for N3-Positive NSCLC

NCT07309952

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +10 more
Locations: Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China

View Trial Details

Recruiting

TRIMPACT: Real-World First-Line Atezolizumab Use in Stage IV NSCLC With PD-L1 ≥50%

NCT07279402

Conditions: Atezolizumab, Bronchial Neoplasms, Carcinoma, Bronchogenic, +11 more
Locations: Adana City Hospital Adana, Turkey (Türkiye)

Afyonkarahisar Health Sciences University Hospital Afyonkarahisar, Turkey (Türkiye)

Ankara Oncology Training and Research Hospital Ankara, Turkey (Türkiye)

Memorial Ankara Hospital Ankara, Turkey (Türkiye)

View all 25 locations

View Trial Details

Recruiting

Mechanisms of Resistance to Amivantamab in Patients With NSCLC With EGFR Exon 20 Insertion

NCT06247826

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
Locations: Oncologie Polyclinique Bordeaux Nord Aquitaine Bordeaux, France

Centre Hospitalier du Morvan Brest, France

Pneumologie Centre Hospitalier Intercommunal de Créteil Créteil, France

Oncologie, CLCC Dijon Dijon, France

View all 18 locations

View Trial Details

Recruiting

MOnaliZumab in Combination With durvAlumab (MEDI4736) for tRreatmenT of Small Cell Lung Cancer

NCT05903092

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Extensive Stage Small Cell Lung Cancer, +11 more
Locations: Indiana University Melvin and Bren Simon Comprehensive Cancer Center Indianapolis, Indiana, United States

University of Iowa Hospitals and Clinics Iowa City, Iowa, United States

Karmanos Cancer Center (Wayne State University) Detroit, Michigan, United States

University of Virginia Health System Charlottesville, Virginia, United States

View Trial Details

Recruiting

Analysis of Biological Characteristics of Advanced ALK-rearranged NSCLC

NCT05122806

Conditions: ALK Gene Rearrangement Positive, Bronchial Neoplasms, Carcinoma, Bronchogenic, +9 more
Locations: Pneumologie CHU Félix Guyon Saint-Denis, La Réunion, France

Centre Hospitalier d'Aix en Provence Aix-en-Provence, France

Pneumologie CHU Amiens, France

Centre Hospitalier Universitaire Angers, France

View all 46 locations

View Trial Details